For Eye Care Professionals
Bausch + Lomb and Technolas™ Perfect Vision Announce CE Mark Approval for VICTUS™ Femtosecond Laser Platform
Bausch + Lomb Acquires Waicon
Consumers Use Unconventional Alternatives for Contact Lens Solution
New Survey Shows That People Don’t Want to Live a Moment of Life with Poor Eye Sight
WebMD, Bausch + Lomb Join Forces to Help Consumers and Doctors Improve Eye Health
Bausch + Lomb Launches LOTEMAX® Ointment (loteprednol etabonate ophthalmic ointment 0.5%)
Bausch + Lomb names Sheila A. Hopkins Global President Vision Care
Bausch + Lomb Introduces enVista™ Glistening-Free, Hydrophobic IOL in European Union
Bausch + Lomb and Technolas™ Perfect Vision Introduce VICTUS™ Femtosecond Laser Platform at 2011 ESCRS Meeting
Bausch + Lomb Enters Into Definitive Agreement with Technolas Perfect Vision GmbH Acquiring An Option to Purchase Company
Expanded Voluntary Recall and Product Discontinuation of Murocel Methylcellulose Lubricant Ophthalmic Solution USP, 1% Sterile
Majority of Moms Are Prepared to Have the “Big Talks” but Unprepared for Those that May Impact Their Child’s Self-Confidence
Voluntary Recall of Single Lot of Murocel Methylcellulose Lubricant Ophthalmic Solution USP, 1% Sterile
Bausch + Lomb Launches Pharmaceuticals Business in India
New Wettability Study Provides Insights into Common Complaint Among Contact Lens Users
Patients Report BiotrueTM Makes Contact Lens Wear Easier On Their Eyes
Bausch + Lomb’s “The Daily Score” Will Make Daily Disposable Contact Lenses More Accessible to Moms and Kids Across the Country
Bausch + Lomb Storz® Ophthalmics Introduces New Collection of StableGrip™ Vitreoretinal Instruments
Yellox™ (Bromfenac sodium sesquihydrate), the First and Only Twice-Daily Ocular NSAID, Approved by the European Commission Following Positive Opinion from CHMP
Glare and Halos Are Significant Problems for People Wearing Glasses or Contact Lenses